Navigation Links
SyntheZyme Wins Second National Science Foundation Grant to Commercialize Promising Biopesticide
Date:5/17/2011

NEW YORK, May 17, 2011 /PRNewswire/ -- SyntheZyme, a sustainable chemical company founded by Richard Gross, the Herman F. Mark chair and professor of chemical and biological sciences at Polytechnic Institute of New York University (NYU-Poly), has received a $475,000 Phase II Small Business Innovation Research (SBIR) grant from the National Science Foundation.  These competitive awards provide federal support for small, highly innovative technology businesses.

(Logo:  http://photos.prnewswire.com/prnh/20091027/NY99197LOGO)

This is the second SBIR grant for SyntheZyme. The Phase I grant, awarded in January 2010, provided funding to demonstrate the efficacy of one of SyntheZyme's core innovations — a biopesticide developed from a modified yeast strain that can protect grain and produce crops without the use of harmful chemical agents.

Due to tightened regulations and heightened concerns about the health hazards of synthetic chemical pesticides, Gross says that a safe alternative is increasingly critical. "This continued support from the National Science Foundation will help us take the final steps toward our goal — offering a safe and superior biopesticide that poses no threat to the farmers who handle the materials or to the consumers who buy their produce," Gross said.

In testing, the SyntheZyme product proved highly effective against the three major plant pathogen fungal groups that attack commercially important crops including potatoes, tomatoes, wheat, corn and rice.

The Phase II grant will allow SyntheZyme to complete additional research necessary to commercialize the biopesticide. Plans include optimizing the processes for yeast fermentation and product production, conducting field trials and performing additional toxicity and biodegradation testing.

SyntheZyme has also made significant progress in developing a highly durable, recyclable bioplastic made from yeast and fatty acids from plant oils. This unique material may be a suitable substitute for polyethylene used in disposable gloves, food packaging films and films for ice, trash and produce bags.

SyntheZyme is jointly owned by Dr. Gross and NYU-Poly. The company is also part of the New York City Accelerator for a Clean and Renewable Economy (NYC-ACRE), NYU-Poly's small-business incubator fostering clean technology and renewable energy companies in New York City.

About Polytechnic Institute of New York University

Polytechnic Institute of New York University (formerly Polytechnic University), an affiliate of New York University, is a comprehensive school of engineering, applied sciences, technology and research, and is rooted in a 157-year tradition of invention, innovation and entrepreneurship: i-squared-e. The institution, founded in 1854, is the nation's second-oldest private engineering school. In addition to its main campus in New York City at MetroTech Center in downtown Brooklyn, it also offers programs at sites throughout the region and around the globe. Globally, NYU-Poly has programs in Israel, China and is an integral part of NYU's campus in Abu Dhabi. For more information, visit www.poly.edu.

About SyntheZyme

SyntheZyme is a privately-held sustainable chemical company commercializing the technology developed in the laboratories of Professor Richard A. Gross at the Polytechnic Institute of NYU. Dr. Gross is the Herman F. Mark Professor of Polymer Science and head of the Center for Biocatalysis and Bio-processing of Macromolecules at NYU-Poly. Located in Brooklyn, N.Y., SyntheZyme uses the understanding of biocatalysis to replace petrochemical based industrial chemicals with biobased and biodegradable alternatives. Focusing on chemicals for plastics, pesticides, cosmetics and personal care product ingredients, Nature's chemistry shows the way and provides the tools that are used by SyntheZyme. For more information, visit www.SyntheZyme.com.

About New York City Accelerator for a Clean and Renewable Economy

The New York City Accelerator for a Clean and Renewable Economy (NYC ACRE) is a cleantech/renewable energy initiative of NYU-Poly, seeded by a four year, $1.5M grant from the New York State Energy and Research Development Authority (NYSERDA) aimed at growing an ecosystem of entrepreneurs, international companies, and innovative local businesses that provide solutions to climate and energy issues while growing the cleantech/renewable energy sector and creating jobs in NYC. For more information, visit www.nycacre.com.


'/>"/>
SOURCE Polytechnic Institute of New York University
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spherix Reports Second Quarter Earnings
2. Tapestry Reports Second Quarter 2007 Results
3. Callisto Reports on Second-Quarter 2007 Milestones
4. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. NeurogesX Announces Positive Results from Second Phase 3 Clinical Trial in Postherpetic Neuralgia
11. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 2, 2016  LifeVac, the revolutionary ... included in the Emergency Response Training and Support Services ... excited to have LifeVac become part of the ERTSS ... Founder and CEO of LifeVac. "Having an established network ... and effectively will help leverage our efforts to spread ...
(Date:12/2/2016)... -- PipelineRx, a leading medication management technology company focused ... its SaaS-based telepharmacy platform, PowerGridRx™ , at ... Clinical Meeting and Exhibition, December 5-7 in ... hospital clients nationally, the Company is a leader ... improve pharmacy operations, enhance patient safety, and reduce ...
(Date:12/2/2016)... 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), today ... Inc. ("PSI").  The combination of Texas -based ... -based PSI bring together both company,s clinical expertise and high-touch ... an industry-leading specialty pharmacy. About Maxor ... , , ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... ... years, Doctors on Liens has published a directory of the top doctors working ... When the company started in 1997, the directory was a single page focusing on chiropractors ... directory features a vast array of medical specialists stretching from Sacramento to San ...
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and ... of those affected by autism spectrum disorder (ASD) and other developmental disabilities. The group, ... will give parents and other caregivers the opportunity to share stories and advice, seek ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest campaign, ... standing as living proof that attitude and determination can combine into the most ... spike around the holidays. This campaign will offer patients a new-found hope, by ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research ... labeling, storing, shipping and disposal. The new version is a faster and a ...
(Date:12/2/2016)... Wexford, PA (PRWEB) , ... December 02, 2016 , ... ... manages stress and overall health, day and night. No other wearable health technology on ... management. We wanted to give poeple more meaningful insights about their health than ...
Breaking Medicine News(10 mins):